Hirtle Callaghan & Co’s iShares Global Healthcare ETF IXJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q1
Sell
-400
Closed -$20K 193
2014
Q4
$20K Hold
400
﹤0.01% 378
2014
Q3
$20K Hold
400
﹤0.01% 412
2014
Q2
$19K Hold
400
﹤0.01% 466
2014
Q1
$18K Hold
400
﹤0.01% 458
2013
Q4
$17K Hold
400
﹤0.01% 437
2013
Q3
$16K Buy
+400
New +$15.7K ﹤0.01% 450

Other funds holding IXJ

Hirtle Callaghan & Co's IXJ Position: Q1 2015 in Review

Hirtle Callaghan & Co sold out of iShares Global Healthcare ETF (IXJ) in Q1 2015, closing a stake of 400 shares — an estimated $20K sold.

Hirtle Callaghan & Co first reported a position in IXJ in Q3 2013 and held it in 6 quarters. The position peaked at $20K in Q4 2014. 133 funds tracked by Wall St. Rank hold IXJ as of Q1 2015.

  • Hirtle Callaghan & Co reported no remaining iShares Global Healthcare ETF position as of Q1 2015 after selling out during the quarter.
  • Hirtle Callaghan & Co sold 400 iShares Global Healthcare ETF shares in Q1 2015, an estimated $20K.
  • Hirtle Callaghan & Co first reported a position in iShares Global Healthcare ETF in Q3 2013 and held it in 6 quarters.
  • Hirtle Callaghan & Co's iShares Global Healthcare ETF position peaked at $20K in Q4 2014.
  • 133 funds tracked by Wall St. Rank held iShares Global Healthcare ETF as of Q1 2015.

Based on Hirtle Callaghan & Co's 13F filing for Q1 2015, filed 15 May 2015.